Navigation Links
Bayer USA Foundation Supports Summer Science Education Programs in Pittsburgh, Raleigh, Houston and Tyler, Texas
Date:7/1/2008

d Engineering Mentoring -- is expanding to two new Texas cities -- Houston and Tyler -- and giving two new students that opportunity.

For example, Kemian J. Fry, a 17-year-old senior at John Tyler High School, will spend his summer at the University of Texas at Tyler. There, he will work on a project focused on a particular pest, known as the Glassy Winged Sharpshooter, which has an impact on agricultural economics in certain areas across the United States.

In Houston, a senior at Alief Taylor High School will be interning at Prairie View A&M University, working on a chemical-research project titled, "Oxidation of Alkenes," an area of particular interest to both the pharmaceutical and industrial manufacturing industries.

"With the Bayer USA Foundation's generous gift, we're able to expand Project SEED to these two new, what we term, high-need cities, bringing the total number of communities we serve to 81 in 26 states," said Cecilia Hernandez, Assistant Director, Endowed Program, Education Division, Project SEED. "The students' complex projects, the mentors who assist them and the professional environments in which they work all combine for enormously meaningful experiences that have major impacts on their future career decisions."

According to Project SEED, 90 percent of participants, most of whom are minorities, plan to go on to college, compared to the national rate of 20 percent of all black students and six percent of all Hispanic students who leave high school college-ready. In addition, SEED alumni include Ph.D. scientists, process engineers, chemistry teachers and chemical engineers, among others.

About Bayer Corporation's Making Science Make Sense

Making Science Make Sense (MSMS) is Bayer Corporation's company-wide initiative that advances science literacy through hands-on, inquiry-based science education, employee volunteerism and a public education campaign. Currently, 12 Bayer sites around the country operate loc
'/>"/>

SOURCE Bayer Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. IVCC launches groundbreaking insecticide projects with Bayer and Syngenta
2. AUDIO from Medialink and Bayer: Simple, Focused Ways to Boost Womens Health
3. Bayer HealthCare Cleared to Acquire Citracal(R)
4. Genzyme and Bayer Schering Pharma AG, Germany to Present New Data on Alemtuzumab in Multiple Sclerosis at ECTRIMS
5. Bayer Foundation Grant Creates Graduate Engineering Fellowship at University of Houston
6. AUDIO from Medialink and Bayer: Is Your Pain Reliever Undermining Your Aspirin Therapy?
7. Bayer Temporarily Suspends Global Trasylol(R) Marketing
8. AUDIO from Medialink and Bayer: Lifesaving Benefits of Low-Dose Aspirin Therapy Maintained with Naproxen Sodium
9. Bayer Plants Trees With Chartiers Valley Intermediate School Students, Provides Free Environmental Education Materials
10. Bayer Awards Making Science Make Sense Grant to Girl Scouts
11. Bayer HealthCare Pharmaceuticals and MedAssets Supply Chain Systems Sign a Three-Year Agreement for Magnevist(R) Magnetic Resonance Contrast Media

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)...ption leads to success, study finds , ,...rcise, reduced soda consumption and self-weighing ...gies for adolescents, a new study shows. , Rese...t-control strategies and lifestyle habits. Sixty-t...The responses were grouped into four categories: ,...
(Date:12/4/2009)...patient groups , , FRIDAY, Dec. 4 (Healt... Ewing sarcomas and central nervous system tumors,...rs have found. , The study authors analyzed dat...on pediatric cancers who were enrolled in the Chil...found that the overall cancer recurrence rate was ...
(Date:12/4/2009)... to take breast cancer drug, study finds , ...out side effects are a major reason why only 6 per...cer are willing to take the drug tamoxifen to prev...ort to inform women about the risks and benefits o...igan Comprehensive Cancer Center created a decisio...
(Date:12/4/2009)...4 Today, seven of Florida,s top no...ng the health of Florida,s uninsured and underserv...2009 Sapphire Award ceremony. ,, The Sapphire A...izes and promotes organizations that have demonstr...ithin their communities. ,, Honorees of The 200...
(Date:12/4/2009)...re-FirstCall/ -- Movado Group Inc. (NYSE: MOV ),...a, Georgia, shared in a tribute on December 3, 200...ie Oudin for her stellar performance in the tourna...finalist at the Open since 1999. ,, (Photo: ...84 ) ,, At a celebratory reception held at Brow...
Breaking Medicine News(10 mins):Health News:Teens Lose More Weight Using Healthy Strategies 2Health News:High-Risk Women May Often Avoid Using Tamoxifen 2Health News:Top Nonprofits Honored for Improving Health of Floridians 2Health News:Top Nonprofits Honored for Improving Health of Floridians 3
... May 20, 2009Physicians can and should play a lead...g towards comprehensive reform of the way health c...uaranteed 1.5 percent annual savings in health car...chieving Health Care ReformHow Physicians Can Help...
...al communities in California,s Central Valley , ,...re, one of the nation,s first and leading provider...of nephrology research, today announced their part...e Park in the City of Stockton. Satellite Healthca...
...ostatic intraepithelial neoplasia (HGPIN) carries ...ostate cancer. Research published in the open acce...atients whose extended core biopsy led to an initi...dation Trust and Lancaster University, along with ...
...hareholders to Support the Company,s Twelve Nomine..., Inc. (Nasdaq: AMLN ) today reminded its shareh...l of Amylin,s nominees, including its two new inde...bourne Capital Management, L.L.C. , , Amylin,s 20...
...., May 26 Cogdell Spencer Inc. (NYSE: CSA ) ann...lic offering of 18,000,000 shares of common stock....ters an option to purchase up to an additional 2,7...eds from the offering to fund a $50 million repaym...
...6 , , About Dr. Harold Kohn & Vimpat , A...l compound that affects neurological systems, Haro...hapel Hill , inventor of the recently FDA-approved... of perseverance, and Veronica was thrilled to tha...
Other Medicine News:Health News:Physicians can lead health care reform through payment and delivery system reforms 2Health News:Satellite Healthcare Walks for Kidney Health 2Health News:Amylin Advises All Shareholders to Vote Their Blue Proxy Card Today 2Health News:Amylin Advises All Shareholders to Vote Their Blue Proxy Card Today 3Health News:Amylin Advises All Shareholders to Vote Their Blue Proxy Card Today 4Health News:Cogdell Spencer Announces Commencement of Common Stock Offering 2Health News:Cogdell Spencer Announces Commencement of Common Stock Offering 3Health News:Inventor of Newly Available Vimpat(R) (lacosamide) C-V Meets a Woman Who Experienced Greater Seizure Control With Use of This New Antiepileptic Drug 2Health News:Inventor of Newly Available Vimpat(R) (lacosamide) C-V Meets a Woman Who Experienced Greater Seizure Control With Use of This New Antiepileptic Drug 3
(Date:12/4/2009)... 4 Chemistry World re... Pharmaceutical Research and Manufacturers of Ame...accines in development for HIV/AIDS and related co...products in development include 23 vaccines and 54...cal trials or awaiting approval by the U.S. Food a...
(Date:12/4/2009)...wire-FirstCall/ -- PharmAthene, Inc. (NYSE Amex: ...ntermeasures against biological and chemical threa... results of a study demonstrating the effectivenes... in the New Zealand White (NZW) rabbit. The data ...HHS Public Health Emergency Medical Countermeasure...
(Date:12/4/2009)...4 OrthoAccel Technologies, Inc., d...acceleration device to enhance orthodontics, annou...n course published by PennWell Corporation , a le..., including medicine and dentistry. The course fo..., a summary of treatment biomechanics, factors tha...
Breaking Medicine Technology:U.S. Pharmaceutical Companies Developing 97 New Drugs and Vaccines to Fight HIV/AIDS 2PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 2PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 3PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 4PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 5PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 6AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 2AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 3AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 4DURECT Corporation to Participate in Upcoming Healthcare Conferences 57474 1DURECT Corporation to Participate in Upcoming Healthcare Conferences 57474 2National Survey Reveals Healthcare Providers Technological Readiness to Participate in Electronic Health Records Network 57469 1National Survey Reveals Healthcare Providers Technological Readiness to Participate in Electronic Health Records Network 57469 2National Survey Reveals Healthcare Providers Technological Readiness to Participate in Electronic Health Records Network 57469 3YM BIOSCIENCES REPORTS NIMOTUZUMAB APPROVED FOR MARKETING IN MEXICO 14116 1YM BIOSCIENCES REPORTS NIMOTUZUMAB APPROVED FOR MARKETING IN MEXICO 14116 2YM BIOSCIENCES REPORTS NIMOTUZUMAB APPROVED FOR MARKETING IN MEXICO 14116 3YM BIOSCIENCES REPORTS NIMOTUZUMAB APPROVED FOR MARKETING IN MEXICO 14116 4
... a First-in-Class Biologic Treatment Option Now Av...s with JIA(1,2) -, PRINCETON, N.J., April 8, 2008... announced that the U.S. Food and Drug,Administrat...reducing signs,and symptoms in pediatric patients ...tive polyarticular juvenile idiopathic arthritis (...
...d., April 8, 2008 ImQuest scientists Robert,W. Bu...nted the results of,studies performed with product...ecent Microbicides 2008, an international conferen...icide scientists, developers, and care,givers from...ak by the,Conference organizers, presenting the re...
Other Medicine Technology:U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older 2U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older 3U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older 4U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older 5U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older 6U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older 7U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older 8U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older 9U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older 10ImQuest Scientists Present Important HIV Microbicide Development Results at Microbicides 2008 in Delhi, India 2
Goat Anti-Human IgA, alpha chain Antibody, Colloidal Gold Conjugated, 50 OD
Protein A 50 OD, Colloidal Gold Conjugated/Tagged
Protein A, Gold Ribbon - .25 OD per sq. cm.
Protein G, Gold Ribbon - .50 OD per sq. cm.
Medicine Products: